Barely Significant
← all excerpts

Evaluating efficacy of pregabalin in diabetic peripheral neuropathy pain management.

Korean J Pain · 2026 · PMC13058928 · PMID 41539853

Europe PMCDOI
1
hedged sentence
0.0560
closest p · 1.1× alpha
0.0560
boldest claim

The sentences

showed a trendP = 0.056so close (0.05 < p ≤ 0.1)
Although pregabalin showed a trend toward improvement on the Mahoney Pain Scale (MPS), the difference was not statistically significant compared to the placebo ( P = 0.056).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.